Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cancer with an EGFR targeted immunomodulatory fusion protein

Method of treating cancer with an EGFR targeted immunomodulatory fusion protein

US Patent 9809651 · Granted Nov 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion immunomodulatory proteins and methods for making same2025
Fusion immunomodulatory proteins and methods for making same2025
Fusion immunomodulatory proteins and methods for making same2025
Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein2024
Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein2024
Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein2024
Monoclonal antibody and a method thereof2024
Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targ2021
CTLA4/PD1 targeted/immunomodulatory fusion proteins2021
CTLA4/PD1 targeted/immunomodulatory fusion proteins2021
CTLA4/PD1 targeted/immunomodulatory fusion proteins2021
Fusion immunomodulatory proteins and methods for making same2020